首页|冠心病伴发心律失常患者PCI术后β受体阻滞应用效果及其与ADRB2Gln27Glu基因多态性的关系

冠心病伴发心律失常患者PCI术后β受体阻滞应用效果及其与ADRB2Gln27Glu基因多态性的关系

扫码查看
目的:探究冠心病(CAD)伴发心律失常患者PCI术后β受体阻滞应用效果及其与ADRB2Gln27Glu基因多态性的关系.方法:随机选取2020年3月—2023年3月宜昌市中心人民医院和厦门大学附属翔安医院收治的CAD伴心律失常患者200例作为研究对象,所有患者PCI术后均接受β受体阻滞剂治疗,并接受ADRB2Gln27Glu基因多态性检测,分析患者的基因型分布,比较不同基因型患者的心功能分级、心律失常发作情况、主要心血管不良事件(MACE)差异.结果:不同基因型患者心功能、心律失常发作频次、持续时间、MACE比较,差异无统计学意义(P>0.05).结论:ADRB2Gln27Glu基因多态性对CAD伴心律失常患者PCI术后β受体阻滞剂疗效影响不大.
Application Effect of β Receptor Block in Patients with Coronary Heart Disease Complicated with Arrhythmia After PCI and its Relationship with ADRB2Gln27Glu Gene Polymorphism
Objective:To explore the application effect of β-receptor block after PCI in patients with coronary heart disease (CAD) complicated with arrhythmia and its relationship with ADRB2Gln27Glu gene polymorphism. Methods:A total of 200 patients with CAD and arrhythmia admitted to Yichang Central People's Hospital and Xiang'an Hospital Affiliated to Xiamen University from March 2020 to March 2023 were randomly selected as the research objects. All patients were treated with β-blockers after PCI,and ADRB2Gln27Glu gene polymorphism was detected. The genotype distribution of patients was analyzed,and the differences in cardiac function classification,arrhythmia attack and major adverse cardiovascular events (MACE) of patients with different genotypes were compared. Results:There was no significant difference in cardiac function,arrhythmia frequency,duration and MACE between patients with different genotypes (P>0.05). Conclusion:ADRB2Gln27Glu gene polymorphism has little effect on the efficacy of β-blockers in CAD patients with arrhythmia after PCI.

Coronary heart diseaseArrhythmiaβ-blockerGenetic polymorphism

陈智浩、杨阳、黄志航、蒋金鑫、苏灿锋、周飞

展开 >

厦门大学附属翔安医院心血管内科,福建厦门 361001

宜昌市中心人民医院心血管内科,湖北宜昌 443099

冠心病 心律失常 β受体阻滞剂 基因多态性

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(11)